Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2021 | 262 | 0.74 | Why? |
| Anemia, Hemolytic | 1 | 2017 | 70 | 0.64 | Why? |
| Hemoglobinuria, Paroxysmal | 1 | 2017 | 116 | 0.62 | Why? |
| Dabigatran | 1 | 2018 | 204 | 0.61 | Why? |
| Anemia, Iron-Deficiency | 1 | 2017 | 210 | 0.57 | Why? |
| Antithrombins | 1 | 2018 | 353 | 0.54 | Why? |
| Venous Thromboembolism | 4 | 2021 | 4273 | 0.37 | Why? |
| Endothelial Progenitor Cells | 2 | 2020 | 103 | 0.35 | Why? |
| von Willebrand Factor | 3 | 2021 | 668 | 0.32 | Why? |
| Venous Thrombosis | 2 | 2019 | 2739 | 0.30 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.29 | Why? |
| Heart, Artificial | 1 | 2020 | 35 | 0.22 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 66 | 0.21 | Why? |
| Myelopoiesis | 1 | 2021 | 116 | 0.21 | Why? |
| Antigens, CD19 | 1 | 2020 | 98 | 0.21 | Why? |
| Vascular Endothelial Growth Factor A | 2 | 2021 | 604 | 0.20 | Why? |
| Angiopoietin-2 | 1 | 2020 | 125 | 0.19 | Why? |
| Endoglin | 1 | 2017 | 16 | 0.18 | Why? |
| Neovascularization, Pathologic | 1 | 2021 | 305 | 0.17 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.17 | Why? |
| Thromboembolism | 2 | 2021 | 2101 | 0.16 | Why? |
| Neovascularization, Physiologic | 1 | 2017 | 160 | 0.16 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 9335 | 0.15 | Why? |
| Endothelium, Vascular | 3 | 2021 | 1751 | 0.14 | Why? |
| Endothelial Cells | 3 | 2021 | 2048 | 0.14 | Why? |
| Anticoagulants | 5 | 2021 | 9563 | 0.13 | Why? |
| Stem Cells | 1 | 2019 | 595 | 0.12 | Why? |
| Interleukin-8 | 1 | 2019 | 964 | 0.12 | Why? |
| Fibrin Fibrinogen Degradation Products | 4 | 2021 | 5993 | 0.12 | Why? |
| Hematology | 1 | 2019 | 649 | 0.12 | Why? |
| Pulmonary Medicine | 1 | 2019 | 706 | 0.12 | Why? |
| Nuclear Medicine | 1 | 2019 | 585 | 0.11 | Why? |
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 595 | 0.11 | Why? |
| Thrombophilia | 2 | 2021 | 1935 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2017 | 915 | 0.10 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.10 | Why? |
| Ischemia | 1 | 2017 | 901 | 0.10 | Why? |
| Hospital Mortality | 6 | 2021 | 22087 | 0.09 | Why? |
| Anesthesiology | 1 | 2019 | 1163 | 0.09 | Why? |
| Gene Expression Regulation | 1 | 2020 | 4020 | 0.09 | Why? |
| Kaplan-Meier Estimate | 3 | 2021 | 4260 | 0.08 | Why? |
| Paris | 2 | 2021 | 1287 | 0.08 | Why? |
| France | 5 | 2021 | 12074 | 0.08 | Why? |
| Survival Rate | 1 | 2021 | 9206 | 0.08 | Why? |
| Diagnosis, Differential | 2 | 2019 | 7220 | 0.08 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 1322 | 0.07 | Why? |
| Aged | 10 | 2021 | 215776 | 0.07 | Why? |
| Proportional Hazards Models | 3 | 2021 | 6543 | 0.07 | Why? |
| Intensive Care Units | 2 | 2021 | 29594 | 0.06 | Why? |
| Male | 12 | 2021 | 367725 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.06 | Why? |
| Middle Aged | 11 | 2021 | 270681 | 0.06 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.06 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.06 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2021 | 77 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Placenta Growth Factor | 1 | 2021 | 93 | 0.05 | Why? |
| E-Selectin | 1 | 2020 | 55 | 0.05 | Why? |
| Molecular Weight | 1 | 2021 | 249 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2019 | 4927 | 0.05 | Why? |
| Collagen | 1 | 2021 | 222 | 0.05 | Why? |
| Patient Admission | 3 | 2021 | 5250 | 0.05 | Why? |
| Tachycardia | 1 | 2020 | 239 | 0.05 | Why? |
| Female | 10 | 2021 | 380317 | 0.05 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.04 | Why? |
| Hindlimb | 1 | 2017 | 21 | 0.04 | Why? |
| Adipogenesis | 1 | 2017 | 38 | 0.04 | Why? |
| Chondrogenesis | 1 | 2017 | 19 | 0.04 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Blood Coagulation | 2 | 2021 | 2768 | 0.04 | Why? |
| Early Medical Intervention | 1 | 2021 | 487 | 0.04 | Why? |
| Biomarkers | 4 | 2021 | 23361 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2019 | 501 | 0.04 | Why? |
| Phenotype | 2 | 2019 | 4037 | 0.04 | Why? |
| Cell Adhesion | 1 | 2017 | 230 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2017 | 172 | 0.04 | Why? |
| Cells, Cultured | 2 | 2019 | 5835 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Chest Pain | 1 | 2020 | 578 | 0.04 | Why? |
| Patients' Rooms | 1 | 2021 | 675 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2021 | 992 | 0.04 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.04 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.03 | Why? |
| Necrosis | 1 | 2017 | 532 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| RNA Interference | 1 | 2017 | 534 | 0.03 | Why? |
| Hemostasis | 1 | 2020 | 811 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.03 | Why? |
| Proteomics | 1 | 2020 | 2481 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Electronic Health Records | 1 | 2021 | 3492 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.02 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Societies, Medical | 1 | 2019 | 6907 | 0.01 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Emergency Medical Services | 1 | 2019 | 3557 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Age Factors | 1 | 2019 | 21039 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.01 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Coronavirus Infections | 1 | 2020 | 253789 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.00 | Why? |
Gendron's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(155)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_